Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Professor of Medicine in the Division of Endocrinology and Metabolism
Research Area(s) / Expertise: Job title: Research Specialist and Post-Doctoral Cardiology Fellow
John Petrie
Job title: Professor of Diabetic Medicine
Professor Petrie graduated from Edinburgh University medical school in 1989. His early clinical training was in Glasgow followed by a PhD on insulin sensitivity and endothelial function (1997) and further clinical and postdoctoral training at the University of Glasgow. He was Reader in Diabetic Medicine at the University of Dundee from 2003 where he led the initiation and successful establishment… View more
Research Area(s) / Expertise: Job title: Professor of Medicine and Pharmacology and Chief of the Section of Endocrinology, Diabetes, and Metabolism
Research Area(s) / Expertise: Job title: Associate Professor of Internal Medicine-Hypertension
Dirk Müller-Wieland
Research Area(s) / Expertise: Job title: Professor of Endocrinology, Metabolism and Diabetes
Prof Dirk Müller-Wieland is a specialist in endocrinology and diabetology at University Hospital Aachen, Department of Medical Sciences (Aachen, DE). He leads the Cardiometric Prevention Working Group and the Clinical Study Center. His research and clinical interests focus on gene regulation, lipid metabolism, fat distribution, insulin resistance and cardiovascular risk.He studied medicine in… View more
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis
Author(s): Ellen Apperloo Added: 1 year ago
In this short interview, Dr Ellen Apperloo (University Medical Center Groningen, Groningen, NL) discusses the key outcomes of tirzepatide in a cohort of type 2 diabetes patients from a pooled post-hoc analysis of the SURPASS 1-5 clinical trials.Findings showed that tirzepatide was associated with reduced urine albumin-creatinine ratio (uACR) compared to all comparators, including semaglutide and… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Research Area(s) / Expertise: Job title: Associate Professor and Senior Lecturer in the Department of Clinical Sciences and Medicine
EASD 2025 Highlights: Updates on Icosapent Ethyl and Cardiometabolic Risk
Author(s): Rahul Aggarwal , Dirk Müller-Wieland Added: 7 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type… View more

Heart Failure

Prevention & Chronic Conditions
SGLTi and GLP-1 in HF
Author(s): Jose L Batista , Tracy Makuvire , Jonathan D Davis , et al Added: 1 year ago

Cardiovascular Kidney Metabolic

Heart Failure